Trial NCT05474690

View at ClinicalTrials.gov 
Org. Study IDs: HNCH-BC010

Last trial update was posted on 2024-02-26

MeSH Interventions

Carboplatin Cyclophosphamide Docetaxel Epirubicin Pertuzumab Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer HER2-positive Breast Cancer

Stopping Reasons

The new treatment plan for HER2 positive breast cancer has entered the diagnosis and treatment guide. The treatment plan ECHP-THP in this study is not the optimal treatment plan, therefore this study was terminated.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID